Showing results (51-60 of 470) with videos related to

Sort By:
Pageof 47
The Lancet. Rheumatology|January 16, 2025
Baricitinib in early polymyalgia rheumatica (BACHELOR): a randomised, double-blind, placebo-controlled, parallel-group trialAlain Saraux, Guillermo Carvajal Alegria, Emmanuelle Dernis, et al.
The Lancet. Rheumatology|February 4, 2024
Nociceptive, neuropathic, or nociplastic low back pain? The low back pain phenotyping (BACPAP) consortium's international and multidisciplinary consensus recommendationsJo Nijs, Eva Kosek, Alessandro Chiarotto, et al.
The Lancet. Rheumatology|January 31, 2024
Intra-articular botulinum toxin A injection for painful base-of-thumb osteoarthritis: a double-blind, randomised, controlled, phase 3 trial (RHIBOT)Christelle Nguyen, Hendy Abdoul, Raphaël Campagna, et al.
The Lancet. Rheumatology|January 22, 2024
Moderators of the effect of therapeutic exercise for knee and hip osteoarthritis: a systematic review and individual participant data meta-analysisMelanie A Holden, Miriam Hattle, Jos Runhaar, et al.
The Lancet. Rheumatology|January 22, 2024
Pain in the joints and beyond; the challenge of rheumatoid arthritisPeter C Taylor
The Lancet. Rheumatology|January 22, 2024
Early infection risk in patients with systemic lupus erythematosus treated with rituximab or belimumab from the British Isles Lupus Assessment Group Biologics Register (BILAG-BR): a prospective longitudinal studyMia Rodziewicz, Sarah Dyball, Mark Lunt, et al.
The Lancet. Rheumatology|January 22, 2024
Evaluation of the safety, efficacy, and mechanism of action of obexelimab for the treatment of patients with IgG4-related disease: an open-label, single-arm, single centre, phase 2 pilot trialCory A Perugino, Zachary S Wallace, Debra J Zack, et al.
The Lancet. Rheumatology|January 22, 2024
Evaluating the safety and short-term equivalence of colchicine versus prednisone in older patients with acute calcium pyrophosphate crystal arthritis (COLCHICORT): an open-label, multicentre, randomised trialTristan Pascart, Pierre Robinet, Sébastien Ottaviani, et al.
The Lancet. Rheumatology|January 22, 2024
1-year results of treatment with rituximab in polymyalgia rheumatica: an extension study of a randomised double-blind placebo-controlled trialThomas E Bolhuis, Diane E Marsman, Alfons A den Broeder, et al.
The Lancet. Rheumatology|January 22, 2024
Multiple switching between the biosimilar adalimumab PF-06410293 and reference adalimumab in patients with active rheumatoid arthritis: a phase 3, open-label, randomised, parallel-group studyRoy M Fleischmann, Wassim Saikali, Sharad Lakhanpal, et al.
Pageof 47